Bisoxatin

DB09219ApprovedSmall molecule

Bisoxatin is a stimulant laxative which increases peristalsis and inhibits absorbtion of water and ions in the intestine . It is marketed in Belgium under the tradename Wylaxine and used...

Mechanism: The precise mechanism of the bisoxatin's stimulant effect and inhibition of water and ion movement is unknown.
Curator reviewed
Primary indication: For use in the treatment of constipation in the absence of bowel obstruction and for surgical preparation of the colon.Curator reviewed
Formula / weight: C₂₀H₁₅NO₄ · 333.343 g/mol (avg)

Resolves to

Compound

UNII7C75N0L7FPCAS17692-24-9ChEBI135955PubChem28689

Clinical / RWD

ATCA06AB09

Structure

InChIKeyBPKUDUSVDVLOPY-UHFFFAOYSA-NSMILESOC1=CC=C(C=C1)C1(OC2=CC=CC=C2NC1=O)C1=CC=C(O)C=C1

What you can answer from here — as of February 21, 2021

1,023Drug interactionsStructured to mechanism, not free text

1ATC codeIncluding every combination product, plus 5 drug categories

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Bisoxatin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account